Page 26 - Revista científica HMVM ::: Hospital General de Agudos "Magdalena V. de Martínez"
P. 26

26                                    REVISTA CIENTÍFICA HMVM - IV




       CONCLuSIóN

        Es  posible realizar un protocolo de transfu- 1:1:1. Usar ácido tranexámico en el proceso de
       sión masiva intrahospitalario para brindar una  resucitación. TEG/ROTEM si se encuentra dis-
       mejor atención a los pacientes. Es fundamen-        ponible. Aparte, debemos evitar incompatibili-
       tal una buena comunicación  entre el servicio  dades ABO, mediante una identificación rápida
       de transfusión y el equipo clínico tratante, así  del paciente y  disponibilidad de UGR grupo 0
       como optimizar los tests necesarios de labora-      y  plasma AB  ante  imposibilidad  de  tests  pre-
       torio. El PTM debe estar bien definido, siguien-    transfusionales.  El  uso  de  productos  Rh+  en
       do lineamientos: Transfusión temprana de pla-       pacientes Rh- debe ser determinado por cada
       quetas, plasma y UGR en una razón cercana a  institución.



       REfERENCIAS

       i  Raymer, J. M., Flynn, L. M., & Martin, R. F. (2012). Mas-  xiii  Nunez TC, Voskresensky IV, Dossett LA, Shinall R,
          sive transfusion of blood in the surgical patient. Surgical   Dutton  WD,  Cotton  BA.  Early  prediction  of  massive
          Clinics, 92(2), 221-234.                            transfusion in trauma: simple as ABC (assessment of
       ii  Diab, Y. A., Wong, E. C., & Luban, N. L. (2013). Massi-  blood consumption). J Trauma 2009; 66: 346–52)
          ve transfusion in children and neonates. British journal  xiv  Kuperman,  S.,  Benzadon,  R.,  Cugliari,  M.  S.,  de
          of haematology, 161(1), 15-26.                      Hemoterapia Inmunohematologia, A. A., & Celular, T.
       iii  Seghatchian, J., & Samama, M. M. (2012). Massive   Guías Nacionales para el uso apropiado de los compo-
          transfusion: an overview of the main characteristics and   nentes de la sangre.
          potential risks associated with substances used for co-  xv  Rice T, Morris S, Tortella B, Wheeler A, Christensen
          rrection of a coagulopathy. Transfusion and Apheresis   M.  Deviations  from  evidence-based  clinical  manage-
          Science, 47(2), 235-243.                            ment  guidelines  increase  mortality  in  critically  injured
       iv  Hewitt  PE,  Machin  SJ. ABC  of  transfusion.  Massive   trauma  patients.  Crit  Care  Med.  2012;40:778–786.
          blood transfusion. Br Med J. 1990;300(6717):107–109.   doi:10.1097/CCM.0b013e318236f168.
          doi:10.1136/bmj.300.6717.107.                    xvi  Cotton B a, Au BK, Nunez TC, Gunter OL, Robertson
       v  Stainsby  D,  MacLennan  S,  Hamilton  PJ.  Manage-  AM, Young PP. Predefined massive transfusion proto-
          ment of massive blood loss: a template guideline. Br J   cols are associated with a reduction in organ failure and
          Anaesth. 2000;85(3):487–491. doi:10.1097/00132586-  postinjury complications. J Trauma. 2009;66(1):41–48;
          200106000-00060.                                    discussion 48–49. doi:10.1097/TA.0b013e31819313bb.
       vi  British Committee for Standards in Haematology, Sta-  xvii  H. P. Pham, B. H. Shaz; Update on massive trans-
          insby D, MacLennan S, Thomas D, Isaac J, Hamilton   fusion,  BJA: British Journal of  Anaesthesia,  Volume
          PJ. Guidelines on the management of massive blood   111, Issue suppl_1, 1 December 2013, Pages i71–i82,
          loss. Br J Haematol. 2006;135(5):634–641. doi:10.1111/  https://doi.org/10.1093/bja/aet376
          j.1365-2141.2006.06355.x.                        xviii  Gerlach R, Tolle F, Raabe A, Zimmermann M, Sie-
       vii  Mitra B, Mori A, Cameron P a., Fitzgerald M, Street A,   gemund A, Seifert V. Increased risk for postoperative
          Bailey M. Massive blood transfusion and trauma res-  hemorrhage after intracranial surgery in patients with
          uscitation. Injury. 2007;38(9):1023–1029. doi:10.1016/j.  decreased factor XIII activity: implications of a prospec-
          injury.2007.03.021.                                 tive study. Stroke 2002; 33: 1618–23
       viii  Diab YA, Wong EC, Luban NL. Massive transfusion  xix  Blome M, Isgro F, Kiessling AH, et al. Relationship
          in children and neonates. Br J Haematol 2013; 161: 15   between  factor  XIII  activity,  fibrinogen,  haemostasis
          –26                                                 screening tests and postoperative bleeding in cardio-
       ix  World  Health  Organization.  World  Health  Statistics   pulmonary bypass surgery. Thromb Haemost 2005; 93:
          2009:  Cause-specific  mortality  and  morbidity.  http://  1101–7
          www.who.int/whosis/whostat/   EN_WHS09_Table2.   xx  McIntyre L, Hebert PC, Wells G, et al. Is a restrictive
          pdf]. 2009                                          transfusion strategy safe for resuscitated and critically
       x  Gutiérrez  G,  Reines  HD,  Wulf-Gutiérrez  ME.  Clinical   ill trauma patients? J Trauma. 2004;57(3):563–568; dis-
         review: hemorrhagic shock. Crit Care. 2004;8(5):373–  cussion 568. doi:10.1097/01.TA.0000136158.93864.54.
         381. doi:10.1186/cc2851.                          xxi  Chaiwat  O,  Lang  JD,  Vavilala  MS,  et  al.  Early
       xi  Como JJ, Dutton RP, Scalea TM, Edelman BB, Hess    packed  red  blood  cell  transfusion  and  acute  res-
         JR. Blood transfusion rates in the care of acute trauma.   piratory  distress  syndrome  after  trauma.  Anesthe-
         Transfusion 2004; 44: 809–13                         siology.    2009;110(2):351–360.    doi:10.1097/
       xii  Butler,  R.  K.,  &  Finn,  D.  P.  (2009).  Stress-induced   ALN.0b013e3181948a97.
         analgesia. Progress in neurobiology, 88(3), 184-202.
   21   22   23   24   25   26   27   28   29   30   31